查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1481832

全球糞便移植治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Fecal Transplant Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

全球糞便移植治療市場需求預計將從 2023 年的 18.9 億美元達到近 32.4 億美元的市場規模，2024-2032 年研究期間複合年成長率為 6.18%。

糞便移植療法或糞便微生物移植 (FMT) 是一種醫療程序，涉及將健康捐贈者的糞便物質轉移到受體的胃腸道中，以恢復腸道微生物群的健康平衡。此療法主要治療復發性艱難梭菌（C. difficile）感染，這是一種導致嚴重腹瀉和胃腸道症狀的細菌感染。這種療法的原理是將供體糞便中的有益細菌和微生物重新引入受體腸道，這有助於抑制艱難梭菌等有害細菌的生長，並恢復微生物多樣性和平衡。這種療法在治療復發性艱難梭菌感染方面顯示出很高的成功率，並且正在研究其在其他胃腸道疾病和病症中的潛在應用。

市場動態

腸躁症 (IBD)、艱難梭菌感染 (CDI) 和腸躁症 (IBS) 等胃腸道疾病的流行，推動了對創新治療方案的需求。人們對腸-腦軸以及腸道微生物群在監督免疫功能、代謝和神經健康方面的作用的日益了解，引起了人們對糞便移植療法的興趣，將其作為治療抑鬱症、自閉症譜系障礙和帕金森氏症等疾病的潛在治療方法。此外，糞便處理技術的進步，例如冷凍、冷凍乾燥或膠囊製劑，正在提高糞便移植產品的便利性、穩定性和標準化，從而促進該療法的更廣泛採用和可擴展性。此外，糞便移植治療的支持性監管框架和指南，加上醫療保健支付者報銷範圍的擴大，正在消除准入障礙並推動市​​場擴張。此外，基於微生物組的診斷和個人化醫療方法的出現為糞便移植治療創造了新的機會，作為根據個別患者的微生物組概況和醫療需求量身定做的綜合治療策略的一部分。然而，微生物組研究和替代治療方式的進步可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球糞便移植治療市場的每個細分市場進行了包容性評估。糞便移植治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

糞便移植治療市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按疾病分類

  • 艱難梭菌感染
  • 自閉症、肥胖
  • 帕金森氏症 (PD)
  • 糖尿病
  • 其他

按程式

  • 糞便灌腸
  • 糞便細菌治療
  • 糞便移植
  • 人類用益生菌輸液
  • 糞便輸血

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲糞便移植治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。糞便移植治療市場的主要參與者包括Finch Therapeutics、Rebiotix、Vedanta Biosciences、Seres Therapeutics、杜邦營養與生物科學、OpenBiome、Evelo Biosciences、Microbiome Therapeutics、Daewoong Pharmaceutical、Takecroda Pharmaceutical Company、MaaTbio、BiomX、Mssecrod ，CIPAC療法。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：糞便移植治療 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按疾病分類的市場吸引力分析
    • 按程式進行的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球糞便移植治療市場分析：依疾病分類

  • 按疾病分類概述
  • 歷史和預測數據
  • 按疾病分析
  • 艱難梭菌感染
  • 自閉症、肥胖
  • 帕金森氏症 (PD)
  • 糖尿病
  • 其他

第 6 章：全球糞便移植治療市場分析：按程序

  • 按程序概述
  • 歷史和預測數據
  • 按程序分析
  • 糞便灌腸
  • 糞便細菌治療
  • 糞便移植
  • 人類用益生菌輸液
  • 糞便輸血

第 7 章：全球糞便移植治療市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：糞便移植治療公司的競爭格局

  • 糞便移植治療市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Finch Therapeutics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Rebiotix
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Vedanta Biosciences
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Seres Therapeutics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • DuPont Nutrition & Biosciences
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • OpenBiome
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Evelo Biosciences
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Microbiome Therapeutics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Daewoong Pharmaceutical
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Takeda Pharmaceutical Company
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • MaaT Pharma
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BiomX
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Assembly Biosciences
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Microbiotica
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • CIPAC Therapeutics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112114443

The global demand for Fecal Transplant Therapy Market is presumed to reach the market size of nearly USD 3.24 Billion by 2032 from USD 1.89 Billion in 2023 with a CAGR of 6.18% under the study period 2024-2032.

Fecal transplant therapy, or fecal microbiota transplantation (FMT), is a medical procedure involving fecal matter from a healthy donor that is transferred into a recipient's gastrointestinal tract to reinstate a healthy balance of gut microbiota. This therapy primarily treats recurrent Clostridium difficile (C. difficile) infections, a bacterial infection that causes severe diarrhea and gastrointestinal symptoms. This therapy works by reintroducing beneficial bacteria and microorganisms from the donor's stool into the recipient's gut, which helps suppress the growth of harmful bacteria such as C. difficile and restore microbial diversity and balance. This therapy has shown high success rates in treating recurrent C. difficile infections and is being investigated for its potential applications in other gastrointestinal disorders and conditions.

MARKET DYNAMICS

The spurring prevalence of gastrointestinal disorders, such as inflammatory bowel disease (IBD), clostridium difficile infection (CDI), and irritable bowel syndrome (IBS), is driving the demand for innovative treatment options. The increasing understanding of the gut-brain axis and the role of gut microbiota in overseeing immune function, metabolism, and neurological health drives interest in fecal transplant therapy as a potential therapeutic approach for conditions such as depression, autism spectrum disorders, and Parkinson's disease. Moreover, advancements in fecal processing techniques, such as frozen, lyophilized, or encapsulated formulations, are improving the convenience, stability, and standardization of fecal transplant products, thereby facilitating broader adoption and scalability of the therapy. Furthermore, supportive regulatory frameworks and guidelines for fecal transplant therapy, coupled with increasing reimbursement coverage by healthcare payers, are removing barriers to access and driving market expansion. Additionally, the emergence of microbiome-based diagnostics and personalized medicine approaches is creating new opportunities for fecal transplant therapy as part of comprehensive treatment strategies tailored to individual patients' microbiome profiles and medical needs. However, advancements in microbiome research and alternative treatment modalities may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Fecal Transplant Therapy. The growth and trends of Fecal Transplant Therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Fecal Transplant Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease

  • Clostridium Difficile Infection
  • Autism, Obesity
  • Parkinson's Disease (PD)
  • Diabetes Mellitus
  • Others

By Procedure

  • Fecal Enema
  • Fecal Bacteriotherapy
  • Stool Transplant
  • Human Probiotic Infusion
  • Fecal Transfusion

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Fecal Transplant Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Fecal Transplant Therapy market include Finch Therapeutics, Rebiotix, Vedanta Biosciences, Seres Therapeutics, DuPont Nutrition & Biosciences, OpenBiome, Evelo Biosciences, Microbiome Therapeutics, Daewoong Pharmaceutical, Takeda Pharmaceutical Company, MaaT Pharma, BiomX, Assembly Biosciences, Microbiotica, CIPAC Therapeutics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. FECAL TRANSPLANT THERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease
    • 3.7.2 Market Attractiveness Analysis By Procedure
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FECAL TRANSPLANT THERAPY MARKET ANALYSIS BY DISEASE

  • 5.1. Overview By Disease
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Disease
  • 5.4. Clostridium Difficile Infection Historic and Forecast Sales By Regions
  • 5.5. Autism, Obesity Historic and Forecast Sales By Regions
  • 5.6. Parkinson's Disease (PD) Historic and Forecast Sales By Regions
  • 5.7. Diabetes Mellitus Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL FECAL TRANSPLANT THERAPY MARKET ANALYSIS BY PROCEDURE

  • 6.1. Overview By Procedure
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Procedure
  • 6.4. Fecal Enema Historic and Forecast Sales By Regions
  • 6.5. Fecal Bacteriotherapy Historic and Forecast Sales By Regions
  • 6.6. Stool Transplant Historic and Forecast Sales By Regions
  • 6.7. Human Probiotic Infusion Historic and Forecast Sales By Regions
  • 6.8. Fecal Transfusion Historic and Forecast Sales By Regions

7. GLOBAL FECAL TRANSPLANT THERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE FECAL TRANSPLANT THERAPY COMPANIES

  • 8.1. Fecal Transplant Therapy Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF FECAL TRANSPLANT THERAPY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Finch Therapeutics
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Rebiotix
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Vedanta Biosciences
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Seres Therapeutics
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. DuPont Nutrition & Biosciences
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. OpenBiome
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Evelo Biosciences
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Microbiome Therapeutics
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Daewoong Pharmaceutical
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Takeda Pharmaceutical Company
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. MaaT Pharma
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. BiomX
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Assembly Biosciences
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Microbiotica
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. CIPAC Therapeutics
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Disease (USD MN)
  • Clostridium Difficile Infection Market Sales By Geography (USD MN)
  • Autism, Obesity Market Sales By Geography (USD MN)
  • Parkinson's Disease (PD) Market Sales By Geography (USD MN)
  • Diabetes Mellitus Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Procedure (USD MN)
  • Fecal Enema Market Sales By Geography (USD MN)
  • Fecal Bacteriotherapy Market Sales By Geography (USD MN)
  • Stool Transplant Market Sales By Geography (USD MN)
  • Human Probiotic Infusion Market Sales By Geography (USD MN)
  • Fecal Transfusion Market Sales By Geography (USD MN)
  • Global Fecal Transplant Therapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Fecal Transplant Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Fecal Transplant Therapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Disease
  • Market Attractiveness Analysis By Procedure
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Disease (USD MN)
  • Clostridium Difficile Infection Market Sales By Geography (USD MN)
  • Autism, Obesity Market Sales By Geography (USD MN)
  • Parkinson's Disease (PD) Market Sales By Geography (USD MN)
  • Diabetes Mellitus Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Procedure (USD MN)
  • Fecal Enema Market Sales By Geography (USD MN)
  • Fecal Bacteriotherapy Market Sales By Geography (USD MN)
  • Stool Transplant Market Sales By Geography (USD MN)
  • Human Probiotic Infusion Market Sales By Geography (USD MN)
  • Fecal Transfusion Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.